Group items tagged

KT3: Clinical concept and advanced whole body application is organized by Texas Children's Hospital and will be held on Jan 26, 2018 at Texas Children's Hospital, Houston, Texas, USA. This CME Conference has been approved for a maximum of 8 CCUs or 8 contact hours. Course Description : The KT3 course combines the Kinesio Taping Method foundational concepts of KT1&KT2 with advanced clinical concepts. The course provides lab time for attendees to practice their skills on the new concepts through a variety of clinical applications. The KT3 course is designed to allow the Certified Kinesio Taping Instructor (CKTI) to cater specific clinical applications to address specific professions. Upon completion of this course and prerequisite KT1&KT2 seminar, attendees will be eligible to request and take the exam to become a Certified Kinesio Taping Practitioner (CKTP). Note: Students can request to take the exam but will not be eligible to receive a CKTP certificate until they graduate. Course Objectives are : * Review the basic concepts of the Kinesio Taping Method * Explain and apply advanced concepts of the Kinesio Taping Method * Review epidermis, dermis, and fascial anatomy as it is related to Kinesio Taping * Utilize and demonstrate application skills in guided laboratory sessions * Apply the Kinesio Taping Method to stimulate epidermis, dermis, and fascial response * Apply advanced clinical taping techniques for treatment of the spine, neurological conditions, and upper/lower extremity dysfunction

Internal medicine patients are frequently prescribed potentially inappropriate medications (PIMs), but screening tools can detect clinically relevant PIMs, according to a study published online Oct. 8 in the Journal of Clinical Pharmacy and Therapeutics. Anne-Laure Blanc, Pharm.D., Ph.D., from Geneva University Hospitals in Switzerland, and colleagues compared two PIM-screening tools -- STOPP/START and PIM-Check -- in a general internal medicine ward. They also analyzed a random sample of 50 patients hospitalized in 2013, whose readmission within 30 days of discharge had been potentially preventable, and 50 sex-and age-matched patients who were not readmitted. The researchers found that across the whole ward population, PIM-Check and STOPP/START detected 1,348 and 537 PIMs, respectively, which was the equivalent of 13.5 and 5.4 PIMs per patient. PIM-Check had a substantially shorter screening time versus STOPP/START (four versus 10 minutes). Of the PIMs detected using PIM-Check and STOPP/START, the clinical pharmacist found 45 percent and 42 percent, respectively, to be clinically relevant to individual patients' cases. There were no significant differences in the rates of detected and clinically relevant PIMs between readmitted and nonreadmitted patients.